Whitehawk Therapeutics, Inc. WHWK
3.74
(0.12)
(3.11%)
as of 25 Sep
- Market cap
- $220.1M
- P/E
- 0.0×
Follow WHWK
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
— | — | — | — |
+8 more quarters Free account |
EV/Sales |
— | — | — | — | |
EV/FCF |
— | — | — | — | |
Quick Ratio |
17.16 | 11.13 | 10.03 | 16.51 | |
Current Ratio |
17.38 | 11.36 | 10.26 | 16.76 | |
Net Debt/EBITDA |
10.29 | 5.16 | 5.67 | 8.03 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.87 | 1.00 | 0.74 | 0.87 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow Yield |
— | — | — | — | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.18) | (0.32) | (0.28) | (0.22) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(0.18) | (0.32) | (0.28) | (0.22) | |
Cash per Share |
2.29 | 1.78 | 2.35 | 2.35 | |
Shareholders Equity per Share |
2.21 | 1.68 | 2.20 | 2.27 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
2.21 | 1.68 | 2.20 | 2.27 | |
Free Cash Flow |
(14.53) | (22.21) | (17.23) | (15.38) | |
Working Capital |
181.35 | 114.49 | 134.49 | 155.19 | |
Capital Expenditures |
— | — | 0.00 | 0.00 | |
Net Current Asset Value |
181.35 | 114.49 | 134.49 | 155.19 | |
EV/EBIT |
— | — | — | — | |
Capex to Sales |
— | — | 0.00 | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% | |
| Other line items | |||||
Average Payables |
2.22 | 2.70 | 1.54 | 1.50 | |
Average Assets |
187.41 | 180.62 | 110.57 | 126.36 | |
Average Common Equity |
177.50 | 168.95 | 94.39 | 113.02 |
Columns are period end dates